Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Articles published by bioAffinity Technologies, Inc.

< Previous 1 2 3 4 Next >

bioAffinity Technologies Advances New Product Development Initiatives to Accelerate Next Phase of Growth

April 24, 2024

From bioAffinity Technologies, Inc.

Via Business Wire

bioAffinity Technologies Expands Campaign to Support American Cancer Society Initiative for Lung Cancer Screening

April 09, 2024

From bioAffinity Technologies, Inc.

Via Business Wire

bioAffinity Technologies Reports Fourth Quarter and Full Year 2023 Financial Results

April 01, 2024

From bioAffinity Technologies, Inc.

Via Business Wire

bioAffinity Technologies Announces Closing of $2.5 Million Registered Direct Offering and Concurrent Private Placement

March 08, 2024

From bioAffinity Technologies, Inc.

Via Business Wire

bioAffinity Technologies Announces Pricing of $2.5 Million Registered Direct Offering and Concurrent Private Placement

March 06, 2024

From bioAffinity Technologies, Inc.

Via Business Wire

bioAffinity Technologies Reports Accelerating Sales Growth of CyPath® Lung

March 05, 2024

From bioAffinity Technologies, Inc.

Via Business Wire

bioAffinity Technologies News Update

February 21, 2024

From bioAffinity Technologies, Inc.

Via Business Wire

Medical Director of Lung Innovations Network and The Lung Center at Penn Highlands Healthcare, Sandeep Bansal, M.D., Joins bioAffinity Technologies’ Medical and Scientific Advisory Board and Incorporates CyPath® Lung into Medical Practice

February 06, 2024

From bioAffinity Technologies, Inc.

Via Business Wire

bioAffinity Technologies In The News

January 30, 2024

From bioAffinity Technologies, Inc.

Via Business Wire

bioAffinity Technologies Appoints Jamie Platt, Ph.D., to its Board of Directors

December 05, 2023

From bioAffinity Technologies, Inc.

Via Business Wire

CMS Posts Final Payment Determination for bioAffinity Technologies’ CyPath® Lung Effective January 2024

November 30, 2023

From bioAffinity Technologies, Inc.

Via Business Wire

bioAffinity Technologies VP David Elzi, Ph.D., Named to American Society for Cell Biology Post

November 28, 2023

From bioAffinity Technologies, Inc.

Via Business Wire

bioAffinity Technologies Teams with American Cancer Society to Raise Funds for Lung Cancer Screening

November 15, 2023

From bioAffinity Technologies, Inc.

Via Business Wire

bioAffinity Technologies Reports Third Quarter 2023 Financial Results and Provides Business Update

November 14, 2023

From bioAffinity Technologies, Inc.

Via Business Wire

bioAffinity Technologies Names Dallas J. Coleman as National Director of Sales

November 06, 2023

From bioAffinity Technologies, Inc.

Via Business Wire

bioAffinity Technologies to Present at the 8th Annual Dawson James Small Cap Growth Conference

October 10, 2023

From bioAffinity Technologies, Inc.

Via Business Wire

bioAffinity Technologies to Participate in the H.C. Wainwright Global Investment Conference

September 07, 2023

From bioAffinity Technologies, Inc.

Via Business Wire

bioAffinity Technologies Reports Second Quarter 2023 Financial Results and Provides Business Update

August 14, 2023

From bioAffinity Technologies, Inc.

Via Business Wire

AMA Issues CPT Code for bioAffinity Technologies’ CyPath® Lung Test for Early-Stage Lung Cancer

July 12, 2023

From bioAffinity Technologies, Inc.

Via Business Wire

bioAffinity Technologies Presents Research Findings at UMass RNA Therapeutics Symposium

June 15, 2023

From bioAffinity Technologies, Inc.

Via Business Wire

bioAffinity Technologies Presents Research Findings at CYTO 2023

May 22, 2023

From bioAffinity Technologies, Inc.

Via Business Wire

bioAffinity Technologies Reports First Quarter 2023 Financial Results

May 15, 2023

From bioAffinity Technologies, Inc.

Via Business Wire

bioAffinity Technologies Names Michael Dougherty as Chief Financial Officer

May 01, 2023

From bioAffinity Technologies, Inc.

Via Business Wire

bioAffinity Technologies Presents at Cleveland Clinic Lung Cancer Symposium

April 25, 2023

From bioAffinity Technologies, Inc.

Via Business Wire

bioAffinity Technologies to Ring Nasdaq Closing Bell Today

April 05, 2023

From bioAffinity Technologies, Inc.

Via Business Wire

bioAffinity Technologies Reports Fourth Quarter and Full Year 2022 Financial Results

March 31, 2023

From bioAffinity Technologies, Inc.

Via Business Wire

bioAffinity Technologies Announces Publication of Peer-Reviewed Paper on Proprietary Beads Used in CyPath® Lung for Noninvasive Detection of Early-Stage Lung Cancer

March 28, 2023

From bioAffinity Technologies, Inc.

Via Business Wire

bioAffinity Technologies to Report Fourth Quarter 2022 Financial Results on March 31, 2023

March 24, 2023

From bioAffinity Technologies, Inc.

Via Business Wire

bioAffinity Technologies Appoints Julie Anne Overton Director of Corporate Communications

February 13, 2023

From bioAffinity Technologies, Inc.

Via Business Wire

bioAffinity Technologies Announces Publication of Results of Clinical Trial in Peer-Reviewed Journal Respiratory Research

January 24, 2023

From bioAffinity Technologies, Inc.

Via Business Wire

< Previous 1 2 3 4 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.